1/234
Looks like no tags are added yet.
Substance Abuse
Repeated harmful use of a mood-altering substance that causes impairment to life.
Addiction
A chronic, compulsive, continuous need to use a substance despite harmful consequences, capable of generating physical or psychological distress if left unfulfilled.
Intoxication
A state of disturbance in cognition, perception, behavior, level of consciousness, judgment, and other functions that is directly attributable to the effects of a psychoactive substance.
Tolerance
A state in which the amount of a substance required to achieve the desired effect continually increases, or where a markedly diminished effect occurs with continued use of the same amount.
Withdrawal
The uncomfortable physiological and mental readjustment that accompanies the discontinuation or reduction of an addictive substance.
Schedule I Controlled Substances
Substances classified under the U.S. Controlled Substances Act having no current legal medical use, a high potential for physical and/or psychological dependence, and a high risk for addiction/abuse (e.g., heroin, LSD, marijuana, and MDMA/Ecstasy).
Schedule V Controlled Substances
Substances with accepted legal medical use, limited potential for physical and/or psychological dependence, and low risk for addiction/abuse, such as codeine-based cough medicines (Robitussin).
Schedule VI (Unscheduled) Substances
Substances that are legal without a prescription and available over-the-counter, including alcohol, aspirin, caffeine, nitrous oxide, Nyquil, and tobacco.

Formication
A tactile hallucination characterized by the sensation of insects or bugs crawling on or under the skin.
Naloxone (Narcan)
An opioid antagonist medication administered (such as via a 4mg nasal spray) for the emergency reversal of known or suspected opioid overdose.

Flumazenil (Romazicon)
An antidote medication specifically indicated for reversing the sedative effects and overdose of benzodiazepines.
Intervention Project for Nurses (IPN)
A specialized monitoring and rehabilitation program in Florida established to assist and oversee nurses with substance impairment or psychological disorders.
Standard Drink Equivalents
Beverage volumes containing roughly equivalent quantities of pure alcohol: 12fl oz of beer (5% alcohol), 8–9fl oz of malt liquor (7% alcohol), 5fl oz of table wine (12% alcohol), or 1.5fl oz of 80-proof distilled spirits (40% alcohol).

Binge Drinking
The consumption of 5 or more drinks within a 2-hour timeframe for men or women.
Alcohol Risk for Abuse Thresholds
Alcohol intake exceeding 4 drinks per occasion or 15+ drinks per week in men, and exceeding 3 drinks per occasion or 8+ drinks per week in women.
Legal BAC Impairment Level (0.08%)
The blood alcohol concentration associated with poor muscle coordination (balance, speech, vision, hearing), harder detection of danger, and impaired judgment, self-control, reasoning, and memory.
Potentially Fatal Alcohol Level (+0.4% BAC)
The blood alcohol concentration threshold that can produce respiratory depression, coma, and potential death.
Wernicke's Encephalopathy
An acute neurological complication of chronic alcohol abuse caused by thiamine (vitamin B1) deficiency, presenting with confusion, eye paralysis, and decreased coordination.
Korsakoff Psychosis
A chronic neuropsychiatric complication associated with alcohol use and thiamine deficiency, characterized predominantly by severe memory and learning deficits.
Delirium Tremens (DTs)
A severe, potentially fatal manifestation of alcohol withdrawal starting within 12–48 to 72hours, characterized by extreme agitation, fluctuating disorientation, confusion, hallucinations, autonomic instability, and seizures.
Early to Mild Alcohol Withdrawal Syndrome (AWS)
Clinical findings emerging within 6–12hours of alcohol cessation, including fine tremors, mild diaphoresis, increased heart rate and blood pressure, nausea, vomiting, anorexia, headache, anxiety, irritability, and insomnia.
CAGE Assessment
A four-question alcohol screening tool assessing if the patient has ever felt the need to Cut down, Annoyed by criticism, Guilty about drinking, or needed an Eye-opener drink; a score of 2 or more positive responses indicates a potential alcohol problem.

AUDIT-C
A 3-question alcohol consumption screening instrument scored from 0 to 12, considered positive with a score of ≥4 in men or ≥3 in women.
CIWA-Ar
The Clinical Institute Withdrawal Assessment of Alcohol Scale, Revised, a validated 10-item instrument with a maximum score of 67; scores less than 10 typically do not require additional withdrawal medication.

Richmond Agitation-Sedation Scale (RASS)
A 10-level clinical scoring system ranging from +4 (combative/violent) to −5 (unarousable), with 0 defining an alert and calm patient.

Critical Blood Ethanol Emergency Level
A blood ethanol level between 3mg/mL and 5mg/mL, recognized as a medical emergency requiring urgent protocol initiation.
Transfer Addiction
The development of a new compulsive behavior or substance addiction following the successful cessation or treatment of a primary addiction.
Gallbladder
A small organ located in the right upper quadrant beneath the liver that stores, concentrates between meals, and releases bile during digestion.
Bile Acids
Components of bile that facilitate the digestion and absorption of fats and fat-soluble vitamins (A, D, E, and K).
Sphincter of Oddi
The muscular valve through which bile is released into the bile duct and intestine upon stimulation by eating.
Acute Calculous Cholecystitis
Gallbladder inflammation caused by gallstone obstruction in the cystic duct or common bile duct, representing 90% of cholecystitis cases.
Acalculous Cholecystitis
Gallbladder inflammation occurring without gallstones, often triggered by biliary stasis, severe trauma, AIDS, or diabetes.
Murphy's Sign
A clinical assessment finding where a patient abruptly stops taking a deep breath during right upper quadrant palpation due to severe pain.
RUQ Ultrasound
The initial diagnostic imaging study of choice for suspected acute cholecystitis, with an accuracy rate between 88% and 95%.
HIDA Scan
A diagnostic imaging test indicated for suspected cholecystitis when a right upper quadrant ultrasound is non-definitive.
Laparoscopic Cholecystectomy
A surgical procedure to remove the gallbladder that is safer, associated with fewer complications, and allows faster healing than open surgery.
Open Cholecystectomy
Surgical removal of the gallbladder providing good visualization for exploration, but carrying an increased risk for infection, bleeding, and longer anesthesia.

T-Tube
A T-shaped drainage tube inserted into the common bile duct to maintain bile drainage while the duct heals post-surgery.
Exocrine Function of the Pancreas
The digestive role of the pancreas involving the release of inactive enzymes (amylase, lipase, protease) into the duodenum.
Endocrine Function of the Pancreas
The hormonal role of the pancreas in blood glucose control via insulin secretion (lowers glucose) and glucagon secretion (raises glucose).
Amylase
A pancreatic digestive enzyme secreted in an inactive form that breaks down carbohydrates in the small intestine.
Lipase
A pancreatic digestive enzyme responsible for breaking down fats, acting as the primary diagnostic biomarker for acute pancreatitis.
Protease
A pancreatic digestive enzyme that breaks down proteins upon activation in the small intestine.
Autodigestion
The pathological process in acute pancreatitis where digestive enzymes become activated prematurely inside the pancreas, digesting pancreatic tissue.
Acute Pancreatitis Diagnostic Criteria
Diagnosis established by meeting at least 2 of 3 features: classic epigastric/back pain, serum lipase or amylase ≥3× upper limit of normal, and characteristic imaging findings.
Serum Lipase
The most specific laboratory marker for acute pancreatitis, which supports diagnosis when elevated to greater than 3× the normal limit.
Hypertriglyceridemia
An etiology of acute pancreatitis characterized by markedly elevated blood triglyceride levels (such as 258mg/dL).

Grey Turner's Sign
Flank ecchymosis caused by retroperitoneal blood spreading into surrounding tissue during severe necrotizing pancreatitis.

Cullen's Sign
A late, concerning finding of bluish-purple periumbilical discoloration indicating internal retroperitoneal bleeding in severe pancreatitis.
Systemic Inflammatory Response in Pancreatitis
Widespread inflammatory response triggered by severe pancreatitis that can lead to hypovolemic shock, AKI, ARDS, and multiorgan dysfunction.
Chronic Pancreatitis
Progressive, irreversible scarring (fibrosis) and permanent structural damage to the pancreas from repeated inflammation.
Steatorrhea
Foul-smelling, greasy, oily stool caused by exocrine pancreatic insufficiency and failure to digest and absorb fats.
Fecal Elastase Test
A stool lab test used to assess exocrine pancreatic insufficiency in patients presenting with chronic steatorrhea.

Pancreatic Calcifications
Bright calcified spots seen on an abdominal CT scan that confirm chronic pancreatitis and long-term glandular damage.
Pancrelipase (Creon)
An oral pancreatic enzyme replacement therapy that must be taken with every meal and snack to aid digestion in chronic pancreatitis.
Obstructive Jaundice in Pancreatic Cancer
Yellowing of the eyes and skin resulting from a tumor in the head of the pancreas obstructing the common bile duct, backing up bilirubin.

Whipple Procedure
A surgical resection (pancreaticoduodenectomy) for pancreatic cancer that removes the head of the pancreas, duodenum, gallbladder, and distal common bile duct.

Post-Whipple Complications
Surgical risks following a Whipple procedure including anastomotic leaks, infection, hemorrhage, delayed gastric emptying, diabetes, and malabsorption.
Hepatocytes
Cells arranged in a hexagon pattern around a central vein that make up liver lobules.

Classic Liver Lobule Structure
The functional unit of liver lobes, comprising hepatocytes radiating around a central vein with portal triads (bile duct, portal vein, and hepatic artery) at the periphery.
Portal Vein Blood Supply
Provides 75% of the liver's total blood supply.
Hepatic Artery Blood Supply
Provides 25% of the liver's total blood supply.
Liver Functions
Includes bile production and excretion, protein metabolism, synthesis of clotting factors, fat and carbohydrate metabolism, phagocytosis, medication filtering, hormone metabolism, vitamin/mineral storage, and blood storage.
Risk Factors for Hepatic Dysfunction
Alcoholism, drugs/chemicals, gallbladder disease, and hepatitis.
Hepatitis Pathophysiology
An inflammatory process that damages hepatic cells and interrupts liver function, involving damaged hepatocytes and Kupffer cells, hyperplasia, necrosis, and cellular regeneration.
Prodromal Phase
The preicteric phase of viral hepatitis occurring before jaundice, characterized by abrupt or insidious flu-like symptoms, malaise, anorexia, fatigue, body aches, chills, fever, and mild RUQ abdominal pain.
Icteric Phase
The phase of viral hepatitis beginning approximately 5–10 days after symptom onset, characterized by jaundice, pruritus, light or clay-colored stools, and dark urine.
Convalescent Phase
The phase following jaundice where liver enzymes return to normal, energy levels increase, and GI symptoms become minimal to absent.
Four F's of HAV Transmission
Food, fingers, feces, or floods.
Hepatitis A (HAV)
A usually benign, self-limiting viral infection transmitted via the fecal-oral route with an incubation of 2–6 weeks, abrupt onset, presence of anti-HAV antibodies, and no carrier state.
Hepatitis B (HBV)
A viral infection transmitted through infected blood, body fluids, or perinatally, with a slow onset, incubation of 6–24 weeks, potential for a carrier state (positive HBsAg), and risk of chronic hepatitis or primary liver cancer.
High Risk Groups for HBV
IV drug users, individuals with multiple sexual partners, men who have sex with men (MSM), patients on hemodialysis, and healthcare workers.
Hepatitis C (HCV)
A bloodborne viral infection with slow onset primarily linked to injection drug use, where 70% to 85% of cases progress to chronic hepatitis and chronic liver disease.
Hepatitis Delta (HDV)
A viral infection that occurs strictly in individuals infected with Hepatitis B, transmitted via blood, body fluids, or perinatally, with an incubation of 3–13 weeks and abrupt onset.
Hepatitis E (HEV)
A viral infection transmitted via the fecal-oral route with an incubation of 3–6 weeks and abrupt onset, which is rare in the United States but may be severe in pregnant women.
Chronic Hepatitis
A chronic infection of the liver resulting from HBV, HCV, or HDV that is a primary cause of liver damage leading to cirrhosis, liver cancer, and end-stage liver failure requiring liver transplantation.
Fulminant Hepatitis
A rapidly progressive disease where liver failure often develops within 2–3 weeks after symptom onset, frequently related to HBV with concurrent HDV infection.
Toxic Hepatitis Causes
Acute or chronic alcohol abuse, certain drugs like Acetaminophen, and toxins including Benzene, Halothane, Chloroform, and poisonous mushrooms.
Autoimmune Hepatitis
A cell-mediated immune response against liver cells leading to inflammation, necrosis, fibrosis, scarring, and potentially cirrhosis or liver failure.

Hepatomegaly
Enlargement of the liver beyond its normal physiological dimensions.

Jaundice
A common indicator of hepatic dysfunction manifested as yellowish discoloration of body tissue, classified into hemolytic, hepatocellular, and obstructive types.

Bilirubinuria
The presence of bilirubin in the urine, giving it a dark color, commonly seen in hepatitis and other hepatic conditions.
Diagnostic Immunoglobulin Markers
IgM indicates an acute infection, whereas IgG indicates a past infection.
Alpha Fetoprotein (AFP)
A lab test utilized as a tumor marker for hepatic cancer.
Hepatitis A Treatment
No specific drug therapy; managed with protective measures and self-care, typically resolving via self-healing in about 8 weeks.
Hepatitis B Medications
Severe cases are treated with Heptovir (lamivudine) or Hepsera (adefovir); chronic cases receive interferon alpha or antivirals such as tenofovir or entecavir.
Hepatitis C Antiviral Therapy
Acute cases use Interferon alpha or Pegasys with Ribavirin; chronic cases use combination peginterferon and ribavirin, or newer combination pills such as Harvoni.
Post-Exposure Prophylaxis for HAV
Immune globulin administered IM into a large muscle mass within 2 weeks of exposure.
Post-Exposure Prophylaxis for HBV
Hepatitis B immune globulin (HBIG) administered IM into a large muscle mass within 24 hours of exposure, accompanied by the initiation of the hepatitis B vaccine series.
Management of Hepatitis Fatigue
Planned rest periods and gradual resumption of activity with avoidance of strenuous exertion.
Nutritional Interventions for Hepatitis
Serving several small, well-balanced, nutritious meals per day along with vitamin supplements and healthy snacks.

Ascites
An accumulation of excess fluid within the peritoneal cavity.
Causes of Ascites
Hypoalbuminemia, hyperaldosteronism, and portal hypertension.

Abdominal Paracentesis
A procedure involving the insertion of a needle into the abdomen to drain excess fluid from the peritoneal cavity into a collection container.
Nursing Considerations for Ascites
Monitoring daily weights, measuring abdominal girth, tracking intake & output (I & O), evaluating lab values, and assessing respiratory function.

Cirrhosis
The end result of most chronic liver diseases, marked by irreversible damage to hepatocytes and tissue architecture, commonly associated with alcoholism and chronic viral hepatitis.
Portal Hypertension
Increased pressure in the portal venous system caused by shunting or compromised hepatic blood flow, leading to varices, ascites, splenomegaly, and caput medusae.
Spider Angioma (Spider Nevi)
Dilated vascular lesions on the skin commonly seen as a systemic effect of liver cell failure and portal hypertension.

Esophageal Varices
Dilated veins that develop within the lining of the lower esophagus due to portal hypertension, carrying a 25% to 40% risk of variceal bleeding.
Diagnosis and Treatment of Esophageal Varices
Diagnosed via upper endoscopy and graded based on size/bleeding risk; treated via endoscopic banding.